Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Prospective, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Healthy Unrelated Stem Cell Donors Undergoing Peripheral Blood Progenitor Cell Mobilization

NCT01766934 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT01766934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01766934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Prospective, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Healthy Unrelated Stem Cell Donors Undergoing Peripheral Blood Progenitor Cell Mobilization
Lead sponsor
Sandoz
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
August 29, 2024
Enrollment
245 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell mobilization